Revenue

A new CISO-voted list reveals the 30 startups trusted to secure the AI era as a new report warns that AI adoption is dangerously outpacing security readiness.

Invoking its Revolutionary War past, a small Massachusetts town joins a growing movement challenging federal authority on war, spending, and immigration.

A new Kickstarter promises a full-size arcade that folds into a stylish cabinet, blending retro nostalgia with modern living and console compatibility.

Online sellers in coaching and supplements face account freezes. A new service says prevention is key, offering stable processing for at-risk businesses.

ODAIA's new AI platform moves beyond static segments to treat each doctor as a 'segment of one,' promising to boost engagement and slash marketing waste.

Terrestrial Energy's molten salt reactor clears a major regulatory hurdle, a critical step toward decarbonizing heavy industry and powering the digital economy.

A new partnership embeds payments directly into payroll, promising a unified, end-to-end solution for multinational companies and closing a critical industry gap.

A new 'agentic storefront' is promising 2x conversion rates by giving brands their own AI, challenging the model of ceding customer data to big tech.

Response Pharmaceuticals unveils promising data on RDX-002, a first-in-class drug aimed at preventing a severe side effect of essential mental health drugs.

S2G Investments launches a $1B fund to scale growth-stage firms in food, energy, and oceans, bridging a critical financing gap for market-ready solutions.

Arvinas secures a historic first FDA approval for a PROTAC drug and inks a deal to fuel a deep pipeline targeting cancer and neurodegenerative diseases.

As data breach litigation skyrockets, specialist law firm Mullen Coughlin bolsters its defense with the strategic hire of 30-year trial veteran MaryEllen Conroy.

New platform VibeFlow promises to bring AI coding speed to regulated industries by deploying AI agent teams that maintain compliance and auditability.

A Belgian firm's new biologic gel for diabetic foot ulcers gets a key FDA green light, offering hope against a leading cause of amputations.

Amidst a quarterly loss, Coincheck inks a major deal with telco giant KDDI and expands into institutional ETFs, betting big on a diversified future.

Impulse Biomedical, a Cape Town startup, enters the US market via a Maryland program, bringing a reloadable epi-pen and an ergonomic inhaler sleeve.

A new report reveals widespread 'relaxation guilt' is fueling a burnout crisis. Many are now ditching long trips for short 'daycations' to find relief.

A new optical switch from University of Arizona research is 1,000x faster and uses 99.9% less energy, promising a sustainable future for data centers and AI.

Allytics promotes Jeff Wells to VP, doubling down on AI and predictive targeting to navigate a new era of self-directed B2B technology buyers.

Fueled by personal tragedy and backed by tech titans, a new foundation aims to revolutionize lung cancer detection using AI and genetics for non-smokers.